advertisement
Science News
from research organizations

Major contributor to Alzheimer's disease discovered

Date:
August 9, 2022
Source:
Louisiana State University Health Sciences Center
Summary:
Research reports on a pathway that begins in the gut and ends with a potent pro-inflammatory toxin in brain cells contributing to the development of Alzheimer's disease (AD). They also report a potentially simple way to prevent it.
Share:
advertisement

FULL STORY

Research led by Drs. Yuhai Zhao and Walter J Lukiw at the LSU Health New Orleans Neuroscience Center and the Departments of Cell Biology and Anatomy, Neurology and Ophthalmology, reports for the first time a pathway that begins in the gut and ends with a potent pro-inflammatory toxin in brain cells contributing to the development of Alzheimer's disease (AD). They also report a simple way to prevent it. Results are published inFrontiers in Neurology, available here.

The researchers found evidence that a molecule containing a very potent microbial-generated neurotoxin (lipopolysaccharide or LPS) derived from the Gram-negative bacteriaBacteroidesfragilisin the human gastrointestinal (GI) tract generates a neurotoxin known as BF-LPS.

"LPSs in general are probably the most potent microbial-derived pro-inflammatory neurotoxic glycolipids known," says Dr. Lukiw. "Many laboratories, including our own, have detected different forms of LPS within neurons of the Alzheimer's disease-affected human brain."

In this study, the researchers detail the pathway of BF-LPS from the gut to the brain and its mechanisms of action once there. BF-LPS leaks out of the GI tract, crosses the blood brain barrier via the circulatory system, and accesses brain compartments. Then it increases inflammation in brain cells and inhibits neuron-specific neurofilament light (NF-L,) a protein that supports cell integrity. A deficit of this protein leads to progressive neuronal cell atrophy, and ultimately cell death, as is observed in AD-affected neurons. They also report that adequate intake of dietary fiber can head off the process.

The novel features of this newly described pathological pathway are threefold. The AD-stimulating pathway begins inside of us -- in our GI-tract microbiome -- and therefore is very "locally sourced" and active throughout our lives. The highly potent neurotoxin BF-LPS is a natural by-product of GI-tract-based microbial metabolism.Bacteroides fragilisabundance in the microbiome, which is the source of the neurotoxin BF-LPS, can be regulated by dietary fiber intake.

"Put another way, dietary-based approaches to balance the microorganisms in the microbiome may be an attractive means to modify the abundance, speciation, and complexity of enterotoxigenic forms of AD-relevant microbes and their potential for the pathological discharge of highly neurotoxic microbial-derived secretions that include BF-LPS and other forms of LPS," Lukiw explains.

The researchers conclude that an improved understanding of the interaction between the GI tract-Central Nervous System axis and the GI-tract microbiome and Alzheimer's disease has considerable potential to lead to new diagnostic and therapeutic strategies in the clinical management of Alzheimer's disease and other lethal, progressive, and age-related neurodegenerative disorders.

据估计,美国人吃10 - 15ms of fiber a day on average. The USDA recommends that women up to age 50 consume 25 grams a day and men 38 grams. Over age 50, women and men should consume 21 and 30 grams daily, respectively.

According to the National Institutes of Health, Alzheimer's disease is the most common diagnosis for patients with dementia and the sixth leading cause of death for Americans. Experts estimate that as many as 5.8 million Americans 65 and older have Alzheimer's disease, and the prevalence in the United States is projected to increase to 13.8million by 2050.

LSU Health New Orleans co-authors included Drs. Vivian Jaber and Nathan Sharfman. Aileen Pogue from Alchem Biotech Research in Toronto Canada was also a co-author.

The research was supported by funding from LSU Health New Orleans, the Brown Foundation, the Joe and Dorothy Dorsett Innovation in Science Health Aging Award, and the National Institutes on Aging of the National Institutes of Health.

advertisement

Story Source:

Materialsprovided byLouisiana State University Health Sciences Center.注意:内容可能被编辑风格d length.


Journal Reference:

  1. Aileen I. Pogue, Vivian R. Jaber, Nathan M. Sharfman, Yuhai Zhao, Walter J. Lukiw.Downregulation of Neurofilament Light Chain Expression in Human Neuronal-Glial Cell Co-Cultures by a Microbiome-Derived Lipopolysaccharide-Induced miRNA-30b-5p.Frontiers in Neurology, 2022; 13 DOI:10.3389/fneur.2022.900048

Cite This Page:

Louisiana State University Health Sciences Center. "Major contributor to Alzheimer's disease discovered." ScienceDaily. ScienceDaily, 9 August 2022. .
Louisiana State University Health Sciences Center. (2022, August 9). Major contributor to Alzheimer's disease discovered.ScienceDaily. Retrieved July 5, 2023 from www.koonmotors.com/releases/2022/08/220809141235.htm
Louisiana State University Health Sciences Center. "Major contributor to Alzheimer's disease discovered." ScienceDaily. www.koonmotors.com/releases/2022/08/220809141235.htm (accessed July 5, 2023).

Explore More
from ScienceDaily

RELATED STORIES